A Phase 1 Study To Evaluate The Effect Of Glasdegib On The Cardiac Repolarization In Healthy Subjects

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2017
This is a Thorough QT study intended to estimate the effect of glasdegib at therapeutic exposure and at supra-therapeutic exposure on cardiac repolarization in healthy subjects. This is a randomized, double blind, positive and placebo controlled study with a 6 day washout between successive periods.
Epistemonikos ID: e703522f84344674471d05f1e3bc38775f2f296c
First added on: May 20, 2024